tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,111 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
0Neutral
9Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -2.15, suggesting Crispr Therapeutics AG is a Buy.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 36.85, while Crispr Therapeutics AG’s (CRSP) share price is $34.89, making it a Sell.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 40.11, while Crispr Therapeutics AG’s (CRSP) share price is $34.89, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Apr 10, 2025, 01:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
29.95
31.46
32.74
34.25
35.53
37.04
38.32
Fibonacci
31.46
32.52
33.18
34.25
35.31
35.97
37.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Apr 10, 2025, 01:08 PM
Period
Simple
Exponential
MA5
32.77Buy
33.40Buy
MA10
34.02Buy
34.52Buy
MA20
37.76Sell
36.85Sell
MA50
41.46Sell
40.11Sell
MA100
43.02Sell
42.64Sell
MA200
46.62Sell
46.77Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 34.52, while Crispr Therapeutics AG’s (CRSP) share price is $34.89, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 42.64, while Crispr Therapeutics AG’s (CRSP) share price is $34.89, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $34.89 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 41.46, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $34.89 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 43.02, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $34.89 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 46.62, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Apr 10, 2025, 01:08 PM
Name
Value
Implied Action
RSI (14)
27.45
Buy
STOCH (9,6)
4.60
Buy
STOCHRSI (14)
3.91
Buy
MACD (12,26)
-2.15
Buy
ADX (14)
20.47
Neutral
Williams %R
-98.43
Buy
CCI (14)
-224.57
Buy
ATR (14)
2.27
-
Ultimate Oscillator
26.00
Sell
ROC
-15.25
Sell
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 27.45, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 20.47, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is -224.57, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is -15.25, creating a Sell signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Sell.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 27.45, which suggests CRSP is a Buy.
      What is CRSP’s MACD?
      CRSP’s MACD is -2.15, which suggests CRSP is a Buy.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 32.77, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 37.76, which suggests CRSP is a Sell.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 41.46, which suggests CRSP is a Sell.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 46.62, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -98.43, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is -224.57, which suggests CRSP is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis